Home » Companies » London Stock Exchange » Smith & Nephew

Smith & Nephew

LON:SN: Stock Share Price & Live Data

1896.50 GBX
-4.00 (-0.21%)
2020-01-22 16:35:07 GMT
Price open 1906.50
Close yesterday 1900.50
Market cap 21.78B
Volume 1.12M
Day high 1917.67
Day low 1894.00
Year high 1998.40
Year low 1402.00

About Smith & Nephew

Smith & Nephew was established in 1856 to manufacture medical equipment in the UK. Thomas James Smith, a British pharmacist from Hull, England, became interested in venturing into the business while working as a dispensing chemist. He later died in 1896 allowing his nephew, Nelson Smith to take up leadership of the firm.

The company has grown to become a leading manufacturer and distributor of advanced medical products and services such as wound management materials, trauma, and therapy management products, orthopedic reconstruction equipment, and much more. It has its headquarters in Watford, the UK with operations worldwide. 

One of the remarkable achievements is when the firm acquired a license to produce and distribute a range of Elastoplast products globally in 1928, which enabled the company to grow to become a leading producer of medical supplies worldwide. The firm has continued to evolve through mergers and acquisitions such as Oratec Interventions, Midland Medical Technologies, and Plus Orthopedics and others. The company is currently listed on London Stock Exchange, a component of FTSE 100 Index.


Latest Smith & Nephew News

Smith & Nephew CEO Steps Down; Shares Fall By 7.5%

The current chief executive officer (CEO) of Smith & Nephew has recently announced his departure from the UK based multinational medical equipment manufacturer. Mr. Nawana has highlighted a desire to focus on foreign opportunities as the reason for stepping down. The announcement, according to the update from the market, was not well...

Smith & Nephew share price: Group to buy Osiris Therapeutics for $660m

Companies expect to close transaction in second quarter of the year

Smith & Nephew share price rises as group posts revenue growth

Restructuring costs weigh on profit margin

Smith & Nephew share price dips as JPMorgan trims stance

Investment bank no longer ‘overweight’ on FTSE 100 group

Smith & Nephew share price: Morgan Stanley ‘overweight’ on group

Analysts argue new management should help reinvigorate top-line performance

Smith & Nephew share price: Berenberg lifts valuation on stock

Analysts nevertheless argue improved earnings growth already priced in


Smith & Nephew plc
London Stock Exchange
Last trade time
2020-01-22 16:35:07
Earnings per share

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.